Brief: Lee's Pharma Says Zhaoke (Hk) Ophthalmology Pharma & Nevakar Entered Licensing Agreement
20/10/2020 11:07
Oct 20 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* ZHAOKE (HK) OPHTHALMOLOGY PHARMA & NEVAKAR ENTERED
EXCLUSIVE
LICENSING AGREEMENT
* DEAL FOR DEVELOPMENT, COMMERCIALISATION OF NVK-002 IN
CHINA,
HONG KONG, MACAU, TAIWAN, SOUTH KOREA AND OTHERS
Source text for Eikon: ID:nHKS8Frj3c
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA